Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Statement Of Investor Complaints For The Quarter Ended December 2021

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ami ShahDesignation :- Company Secretary and Compliance Officer
13-01-2022
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018, please find enclosed herewith the letter received from our Registrar and Share Transfer Agent, M/s Link Intime India Private Limited for the quarter ended December 31, 2021. Kindly take the same on your record.
13-01-2022
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Closure of Trading Window

This is to inform you that pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and the Company's Code of Practices & Procedure for Fair Disclosure and Code of Conduct to Regulate, Monitor and Report Trading in the Securities of the Company ('Code'), the trading window for trading in the shares of the company will remain close from January 01, 2022 till 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2021, for all the Designated Persons including their immediate relatives. The trading window will re-open after 48 hours from the announcement to the Stock Exchanges of the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2021. Kindly take the same on record.
29-12-2021
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Newspaper Publication

In terms of Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, please find enclosed herewith the newspaper advertisement published today i.e., Tuesday, December 21, 2021 in Business Standard, English and Mumbai Lakshadeep, Marathi, confirming dispatch of notice of Postal Ballot and providing other information, pursuant to the provisions of Section 108 and 110 of the Companies Act, 2013 read with rules framed thereunder. The above information is also available on the website of the company www.gufic.com Kindly take the same on record
21-12-2021
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

Pursuant to Regulation 30 of the Securities Exchange Board Of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith Postal Ballot notice dated December 10, 2021 along with Explanatory Statement pursuant to Section 102 of the Companies Act, 2013 seeking approval of the Members for re-appointment of Mr. Pankaj J. Gandhi (DIN:00001858) as a Whole Time Director of the Company by way of postal ballot only through remote voting by electronic means ('remote e-voting'). The Postal Ballot Notice is also available on the website of the Company www.gufic.com. Kindly take the same on record.
20-12-2021
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Announcement Under Regulation 30 (LODR)-Outcome Of The Board Meeting Held On December 10, 2021

Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 ('SEBI Listing regulations'), we would like to inform you that the Board of Directors of the Company at its Meeting held today i.e. Friday, December 10, 2021 inter alia have considered and approved the Postal Ballot notice for re-appointment of Mr. Pankaj J. Gandhi as a Whole Time Director of the Company for a period of five consecutive years w.e.f. September 07, 2021, liable to retire by rotation, subject to approval of the shareholders. The postal ballot notice will be made available shortly. We further inform that Mr. Gandhi is not debarred from holding the office of Director by virtue of any SEBI orders or any other such authority. Pursuant to SEBI Circular CIR/CFD/CMD/4/2015 dated September 9, 2015, a brief profile of the aforesaid Director is enclosed herewith as Annexure-I. Kindly take the same on record.
10-12-2021
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

This is in furtherance to our communication dated November 10, 2021 on Earning Conference Call and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, written transcript of the said call held on November 10, 2021 at 5:00 p.m. has been uploaded on the Company's website and can be accessed through the link: http://gufic.com/Notice/Transcript%20of%20Q2%20Earning%20Call.pdf Kindly take the same on record.
16-11-2021
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)Regulations 2015, audio call recording of the Earnings Conference Call held on 10th November, 2021 at 5:00 p.m. has been uploaded on the Company's website and can be accessed through the below link: http://gufic.com/Notice/AUDIORECORDING_10112021.mp3 Written transcript of the same will be submitted in due course. Kindly take the same on record.
10-11-2021
Bigul

Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

In furtherance to our submission dated November 03, 2021 and pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Company will host an Earnings Conference Call for Investors/Analysts on Wednesday, November 10, 2021, at 17:00 hours (IST), during which officials of the Company will discuss the business background/prospects and financial performance of the Company and take questions. The presentation, which would be taken during the said Meeting, is enclosed herewith, for your reference. Kindly take the same on record.
08-11-2021
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Results-Financial Results For The Quarter And Half Year Ended September 30, 2021

Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Regulations'), we wish to inform you that the Board of Directors of the Company at its meeting held on November 03, 2021 inter alia considered and approved the Un-audited Financial Results of the Company for the Quarter and Half Year ended September 30, 2021. In terms of provisions of the said Regulations, we are enclosing herewith a copy of the Un-Audited Financial Results along with Limited Review Report received from the Statutory Auditor of the Company for the Quarter and Half Year ended September 30, 2021. The meeting of the Board of Directors commenced on November 03, 2021 at 5:00 p.m. and concluded at 6.20 p.m. The Q2 Earning Conference Call of the Company is scheduled to be convened on Wednesday, November 10, 2021 at 5:00 p.m., the details of which shall be intimated shortly.
03-11-2021
Next Page
Close

Let's Open Free Demat Account